Education
About Us
Working with TipRanks
Follow Us
Rhythm Pharmaceuticals (RYTM)
NASDAQ:RYTM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 130.13M | $ 77.43M | $ 23.64M | $ 3.15M | $ 0.00 |
| Gross Profit | $ 116.76M | $ 68.13M | $ 21.50M | $ 2.56M | $ -690.00K |
| Operating Income | $ -265.50M | $ -184.36M | $ -179.16M | $ -170.06M | $ -136.57M |
| EBITDA | $ -238.09M | $ -168.46M | $ -174.25M | $ -68.45M | $ -135.88M |
| Net Income | $ -260.60M | $ -184.68M | $ -181.12M | $ -69.61M | $ -130.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 320.56M | $ 275.85M | $ 333.29M | $ 294.86M | $ 172.79M |
| Total Assets | $ 392.27M | $ 332.75M | $ 382.48M | $ 329.52M | $ 187.07M |
| Total Debt | $ 3.94M | $ 1.26M | $ 1.94M | $ 2.55M | $ 3.09M |
| Net Debt | $ -85.20M | $ -58.82M | $ -125.73M | $ -56.70M | $ -97.77M |
| Total Liabilities | $ 227.72M | $ 162.99M | $ 118.22M | $ 45.37M | $ 20.55M |
| Stockholders' Equity | $ 164.55M | $ 169.76M | $ 264.26M | $ 284.15M | $ 166.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -113.88M | $ -136.20M | $ -177.71M | $ -151.44M | $ -122.19M |
| Operating Cash Flow | $ -113.88M | $ -136.16M | $ -173.43M | $ -146.00M | $ -121.98M |
| Investing Cash Flow | $ -48.17M | $ -5.67M | $ 28.03M | $ -62.16M | $ 158.53M |
| Financing Cash Flow | $ 191.24M | $ 74.37M | $ 213.83M | $ 166.48M | $ 2.01M |